SAN JOSE, Calif. , Nov. 15, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2024 Stifel

SAN JOSE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30,

Outset Medical features patient experience poster presentations at Kidney Week 2024 Consensus recommendations for use of catheters in home hemodialysis patients published in Kidney Medicine SAN JOSE, Calif. , Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc.

SAN JOSE, Calif. , Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of

SAN JOSE, Calif. --(BUSINESS WIRE)--Aug. 7, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the second quarter ended June

SAN JOSE, Calif. --(BUSINESS WIRE)--Jul. 24, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that it will release financial results for the second quarter of

SAN JOSE, Calif. --(BUSINESS WIRE)--Jun. 3, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that management will present at the Goldman Sachs 45 th annual

SAN JOSE, Calif. --(BUSINESS WIRE)--May 8, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the first quarter ended March

SAN JOSE, Calif. --(BUSINESS WIRE)--May 6, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k)

SAN JOSE, Calif. --(BUSINESS WIRE)--May 1, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that members of management will participate at the BofA Securities